Delivery Order SPE2DB22D3004-SPE2DB25FNE60
Award Date
10/11/24
Potential Completion Date
10/15/24
Potential Value
$1.2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The $1,196.64 firm fixed-price delivery order is for the supply of 4565223784 ! METHYLERGONOVINE 0.2 MG/ML VLML, a pharmaceutical product. The contract has a completion date of July 24, 2024 and was awarded on July 23, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,196.66 Firm Fixed Price Delivery Order contract is for the supply of 4567616841 - Methylergonovine 0.2 mg/ml Vials. The award is not associated with a set-aside program. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,376.70, is a Delivery Order with a Firm Fixed Price pricing type. The contract is for the supply of 4567556472 ! METHYLERGONOVINE 0.2 MG/ML AMPML, a pharmaceutical product, with a performance period running through March 13, 2025. This award does not have a set-aside designation. AmerisourceBergen...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,176.40 firm fixed price delivery order is for the supply of 4565044319 - METHYLERGONOVINE 0.2 MG TABLET 28S, with an ultimate completion date of July 2, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery...
This federal contract award, valued at $2,393.28, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4567064635 - Methylergonovine 0.2 mg/ml vials, with a final completion date of January 29, 2025. The contract is a Firm Fixed Price Delivery Order with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant...
This federal contract award, valued at $1,794.96, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The award is a delivery order contract for the supply of 4565019375 - Methylergonovine 0.2 mg/ml VLML, a pharmaceutical product, with a completion date of June 28, 2024. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, particularly the Department of Defense...
This federal contract award, valued at $1,007.70, was issued by the Defense Logistics Agency (DLA) to the prime contractor AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award is a Delivery Order contract with a Firm Fixed Price pricing type, and an ultimate completion date of February 19, 2025. The contract covers the procurement of 4567304287 units of Methylergonovine 0.2 mg/ml, a medication used to treat certain postpartum conditions. AmerisourceBergen holds a larger...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4566416810 - Methylergonovine 0.2 mg/ml vials, with a ceiling value of $2,881.54 and a period of performance through November 14, 2024. The contract is a firm-fixed-price delivery order and was not designated as a set-aside. AmerisourceBergen holds a...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the provision of 4564309590 - METHYLERGONOVINE 0.2 MG/ML AMPML, a pharmaceutical product, to the U.S. government. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense, with a ceiling value of $1,087.96 and a completion date of April 18, 2024. This is a delivery order contract with a firm fixed price pricing type. The contract is...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The $7,898.41 firm fixed-price delivery order is for the pharmaceutical product METYLPHEN ER 18MG 100S and has a completion date of July 17, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, which serves as a...